Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India]/ Los Angeles (California) [US], May 11 (ANI/PRNewswire): Wellthy Therapeutics, a global leader in digital health and digital therapeutics, announces the successful completion of its FDA 21 CFR Part 820, FDA 21 CFR Part 11, and HIPAA certification for its disease-agnostic, modular, software-as-a-medical-device (SaMD) platform. These international registrations further solidify the company's commitment to maintaining the highest standards of data security, data privacy, quality and regulatory compliance in the development and manufacturing of digital health solutions for customers in the United States, and worldwide, and reinforce its leadership in the SaMD space. Business News | Wellthy Therapeutics Announces Expansion into the United States - Completes FDA CFR Part 11, FDA CFR Part 820, and HIPAA Certification for Its Platform.